Sat Jan 11 14:00:00 UTC 2025: ## Common Cold Virus, Human Metapneumovirus (hMPV), Highlights Need for Awareness

**Geneva, Switzerland** – Human metapneumovirus (hMPV), a common cause of upper respiratory infections (URIs), is receiving increased attention from global health organizations. While typically causing mild cold-like symptoms, hMPV can lead to severe illness in vulnerable populations, particularly infants, the elderly, and those with pre-existing conditions like asthma or COPD.

First identified in 2001, hMPV spreads through airborne respiratory droplets and contact with contaminated surfaces, similar to other common cold viruses. Its prevalence varies geographically, with temperate regions experiencing peak transmission in late winter and spring alongside other respiratory viruses like influenza and RSV. However, hMPV infections occur year-round at lower levels.

Symptoms range from mild cold-like symptoms to more severe conditions such as pneumonia and bronchiolitis, characterized by wheezing, difficulty breathing, and persistent fever. Individuals experiencing severe symptoms should seek immediate medical attention.

Currently, there is no licensed vaccine for hMPV, though research is ongoing. Treatment focuses on managing symptoms with over-the-counter medications and supportive care, such as rest and hydration. Antiviral medications are not currently available. While most individuals recover within a few days, high-risk groups should consult their physician even with mild symptoms. A PCR test provides accurate and timely diagnosis.

The World Health Organization (WHO) emphasizes the importance of monitoring hMPV trends and its potential evolution. The organization is collaborating with global experts to track changes in the virus’s severity and transmission patterns. The WHO also stresses preventative measures like maintaining a strong immune system and practicing good hygiene, similar to preventing other respiratory illnesses. Differentiating hMPV from other respiratory illnesses with similar symptoms, such as COVID-19 and influenza, which have specific antiviral treatments, requires proper diagnostic testing to ensure appropriate medical management.

Read More